tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

XAIR Stock Latest News

Beyond Air prices 9.64M shares at $1.66 in registered direct offering
The FlyBeyond Air prices 9.64M shares at $1.66 in registered direct offering
1M ago
XAIR
Beyond Air® Announces Pricing of $16.0 Million Registered Direct Offering of Common Stock and Warrants
PremiumPress Releases
Beyond Air® Announces Pricing of $16.0 Million Registered Direct Offering of Common Stock and Warrants
1M ago
XAIR
Beyond Air’s Annual Meeting: Board Elections and Incentive Plan Expansion
PremiumCompany Announcements
Beyond Air’s Annual Meeting: Board Elections and Incentive Plan Expansion
1M ago
8K
XAIR
Beyond Air’s Former CMO Becomes Paid Consultant
PremiumCompany Announcements
Beyond Air’s Former CMO Becomes Paid Consultant
2M ago
8K
XAIR
Beyond Air® Reports Financial Results for Third Quarter of Fiscal Year 2024
PremiumPress Releases
Beyond Air® Reports Financial Results for Third Quarter of Fiscal Year 2024
2M ago
XAIR
XAIR Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsXAIR Upcoming Earnings Report: What to Expect?
2M ago
XAIR
Beyond Air® Schedules Third Fiscal Quarter 2024 Financial Results Conference Call and Webcast
PremiumPress Releases
Beyond Air® Schedules Third Fiscal Quarter 2024 Financial Results Conference Call and Webcast
3M ago
XAIR
Beyond Cancer™ Phase 1 Study Clears Cohort 1 in Patients with Advanced Relapsed or Refractory Unresectable Primary or Metastatic Cutaneous or Subcutaneous Solid Tumors
PremiumPress Releases
Beyond Cancer™ Phase 1 Study Clears Cohort 1 in Patients with Advanced Relapsed or Refractory Unresectable Primary or Metastatic Cutaneous or Subcutaneous Solid Tumors
4M ago
XAIR
Beyond Cancer reports Phase 1 study of UNO clears first cohort
PremiumThe Fly
Beyond Cancer reports Phase 1 study of UNO clears first cohort
4M ago
XAIR
Beyond Air up 14% at $1.94 after disclosing insider buy
PremiumThe Fly
Beyond Air up 14% at $1.94 after disclosing insider buy
4M ago
XAIR
Beyond Air director Carey buys 1.2M common shares
PremiumThe Fly
Beyond Air director Carey buys 1.2M common shares
4M ago
XAIR
Beyond Air® To Participate in the 35th Annual Piper Sandler Healthcare Conference
PremiumPress Releases
Beyond Air® To Participate in the 35th Annual Piper Sandler Healthcare Conference
5M ago
XAIR
Beyond Air price target lowered to $10 from $14 at Truist
PremiumThe FlyBeyond Air price target lowered to $10 from $14 at Truist
5M ago
XAIR
Beyond Air price target lowered to $10 from $13 at BTIG
PremiumThe Fly
Beyond Air price target lowered to $10 from $13 at BTIG
5M ago
XAIR
Beyond Air reports Q2 EPS (51c), consensus (47c)
PremiumThe Fly
Beyond Air reports Q2 EPS (51c), consensus (47c)
5M ago
XAIR
Beyond Air® Reports Financial Results for Second Quarter of Fiscal Year 2024
PremiumPress Releases
Beyond Air® Reports Financial Results for Second Quarter of Fiscal Year 2024
5M ago
XAIR
XAIR Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
XAIR Upcoming Earnings Report: What to Expect?
5M ago
XAIR
Beyond Cancer™ Presents Positive First-in-Human Clinical Data for Ultra-High Concentration Nitric Oxide (UNO) Therapy in Solid Tumors During the Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting
PremiumPress Releases
Beyond Cancer™ Presents Positive First-in-Human Clinical Data for Ultra-High Concentration Nitric Oxide (UNO) Therapy in Solid Tumors During the Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting
6M ago
XAIR
Beyond Cancer presents first-in-human clinical data for UNO therapy
PremiumThe Fly
Beyond Cancer presents first-in-human clinical data for UNO therapy
6M ago
XAIR
Beyond Air® Schedules Second Fiscal Quarter 2024 Financial Results Conference Call and Webcast
PremiumPress ReleasesBeyond Air® Schedules Second Fiscal Quarter 2024 Financial Results Conference Call and Webcast
6M ago
XAIR
Beyond Air® To Participate in the Truist Securities BioPharma Symposium
PremiumPress Releases
Beyond Air® To Participate in the Truist Securities BioPharma Symposium
6M ago
XAIR
Beyond Cancer™ Publishes Pre-Clinical Data in Cells Demonstrating that the Combination of Ultra-High Concentration Nitric Oxide (UNO) and Anti-mPD-1 Therapy Improves Tumor Regression Rates and Survival in Mice
PremiumPress Releases
Beyond Cancer™ Publishes Pre-Clinical Data in Cells Demonstrating that the Combination of Ultra-High Concentration Nitric Oxide (UNO) and Anti-mPD-1 Therapy Improves Tumor Regression Rates and Survival in Mice
6M ago
XAIR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >